AP NEWS
ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Smiths Detection confirms BioFlash capable of airborne COVID-19 detection

April 13, 2021 GMT

LONDON--(BUSINESS WIRE)--Apr 13, 2021--

Smiths Detection, a global leader in threat detection and security screening technologies, confirms its BioFlash® Biological Identifier is capable of detecting airborne COVID-19 following tests conducted by the University of Oregon, positioning the technology as an effective environmental monitoring tool for use in indoor public spaces.

ADVERTISEMENT

The University of Oregon tests were performed in quarantine and isolation spaces known to have individuals who had tested positive for SARS-CoV-2 (the virus causing COVID-19). The BioFlash identified aerosolised virus, at the detectable range generated via human shedding, in rooms where the presence of SARS-CoV-2 was also detected by environmental swabs. The BioFlash technology allows for onsite confirmation of these results in under three minutes.

The findings build upon previously reported USAMRIID test results from February 2021 that determined Smiths Detection’s BioFlash® detected aerosolized SARS-CoV-2 in a controlled release.

“These test results verify the accuracy and reliability of the BioFlash in a real-world setting,” said Roland Carter, President, Smiths Detection. “An effective monitoring tool such as the BioFlash can contribute to creating a COVID-secure environment indoors, in places such as hospitals, schools and commercial buildings, as well as provide invaluable data for better understanding the behaviour of this virus. We will continue to explore the capabilities of this technology with a view to informing COVID-19 mitigation strategies.”

ADVERTISEMENT

The product is available immediately in the US and arrangements for a global roll out currently underway.

###

About BioFlash Biological Identifier

The BioFlash® Biological Identifier is powered by CANARY® technology (a cell-based biosensor) and is combined with proprietary aerosol-collection techniques to provide rapid, sensitive and specific identification of biological-threat agents including viruses, toxins and bacteria.

About Smiths Detection

Smiths Detection, part of Smiths Group, is a global leader in threat detection and screening technologies for aviation, ports and borders, defence and urban security markets. Our experience and history across more than 40 years at the frontline enables us to deliver the solutions needed to protect society from the threat and illegal passage of explosives, prohibited weapons, contraband, toxic chemicals and narcotics.

For more information visit http://www.smithsdetection.com/

View source version on businesswire.com:https://www.businesswire.com/news/home/20210413005093/en/

CONTACT: FTI Consulting:

Tom Hufton/Georgina Reeves

sc.smithsdetection@fticonsulting.com, +44 (0)20 3727 1000

Smiths Detection:

Sophie Mills, Global Communications Manager

sophie.mills@smithsdetection.com, +44 (0)7384236474

KEYWORD: EUROPE UNITED STATES UNITED KINGDOM NORTH AMERICA OREGON

INDUSTRY KEYWORD: TECHNOLOGY RESEARCH INFECTIOUS DISEASES SECURITY BIOTECHNOLOGY HEALTH UNIVERSITY SCIENCE EDUCATION

SOURCE: Smiths Detection

Copyright Business Wire 2021.

PUB: 04/13/2021 07:00 AM/DISC: 04/13/2021 07:01 AM

http://www.businesswire.com/news/home/20210413005093/en